Vaginal microbiota and microenvironment (VMM)

The vaginal microbiota and microenvironment represent a complex biological system primarily dominated by Lactobacillus species in healthy individuals of reproductive age. This ecosystem plays a critical role in female reproductive health by maintaining an acidic environment (pH < 4.5) through the production of lactic acid, which serves as a primary defense mechanism against pathogenic colonization. Beyond pH regulation, the microbiota interacts closely with the host immune system and vaginal epithelium to provide a protective barrier against infections such as bacterial vaginosis, sexually transmitted infections, and yeast overgrowth. Dysbiosis, characterized by a shift from Lactobacillus dominance to a diverse population of anaerobic bacteria, is linked to significant clinical outcomes including increased susceptibility to HIV, pelvic inflammatory disease, and adverse pregnancy outcomes like preterm birth. Therapeutic strategies targeting this environment include traditional antibiotics to eliminate pathogens and emerging live biotherapeutic products designed to restore healthy microbial composition. Understanding the interplay between microbial metabolites, host immunity, and hormonal influences is essential for developing targeted interventions for gynecological and obstetric health.

Other names

Vaginal microbiomeVaginal floraVaginal ecosystemVaginal niche

Therapeutic interventions aim to restore the dominance of beneficial Lactobacillus species, which produce lactic acid to maintain a low pH (typically <4.5) and secrete antimicrobial compounds like hydrogen peroxide and bacteriocins to inhibit the overgrowth of anaerobic pathogens. Antibiotics target specific anaerobic or fungal overgrowth, while live biotherapeutic products (LBPs) attempt to re-colonize the niche with protective commensals.